Tenon Medical shares surge 12.4% after-hours as company withdraws public offering decision, sparking market optimism.

Tenon Medical (NASDAQ:TNON) surged 12.4% in after-hours trading following a buy rating driven by strategic acquisitions and product innovations, as reported by Tipranks on October 22, 2025. The firm highlighted advancements in its Catamaran SI Joint Fusion System, including expanded physician use of the JIB Instrument Kit, signaling growing market confidence in its orthopedic solutions. This positive analyst sentiment aligns with recent operational milestones, such as the first patients treated with the new instrument kit in September and the withdrawal of a contentious public offering in late September, which had previously caused volatility. The rating upgrade suggests renewed optimism about Tenon’s competitive positioning and growth potential in the spinal fusion market.